Research Article
Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
Matthew Oliver Brook et al.
DOI: 10.1136/bmjopen-2022-061864